Rianne Eva van Rijswijk

Ms. Rianne Eva van Rijswijk

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Journal of Vascular Surgery
Verified
Journal Article
Open access
RRRianne Eva van Rijswijk
Rianne Eva van Rijswijk
EJErik Groot Jebbink
Erik Groot Jebbink
CZClark J. Zeebregts
Clark J. Zeebregts
MRMichel M.P.J. Reijnen
Michel M.P.J. Reijnen
The long-term outcomes after endovascular abdominal aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs) have been inferior to those after open surgical repair with regard to reinterventions and late mortality. AAA sac remodeling after EVAR has been associated with endoleaks, reinterventions, and mortality. Therefore, knowledge of the predictors of AAA sac remodeling could indirectly give insight into the long-term EVAR outcomes. In the present review, we aimed to provide an overview of the evidence for anatomic predictors of positive and negative AAA sac remodeling after EVAR. A systematic literature review and analysis were conducted in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) and Cochrane guidelines. The PubMed and Scopus databases were searched using terms of AAA sac growth, shrinkage, and remodeling. Eligible studies were identified, and only those studies that had included currently used endografts were included. A total of 19 studies that had reported on a total of 27 anatomic parameters of the aortoiliac anatomy were included. Only 4 parameters had been investigated by more than five studies, 7 parameters were investigated by three to five studies, 7 parameters were investigated by two studies, and 9 parameters were investigated by one study. For the presence of neck thrombus, three of four studies had reported similar results, indicating that the presence of neck thrombus might predict for less AAA sac shrinkage. AAA thrombus, the total AAA volume, the flow-lumen volume, aortic calcification, and the number of hostile neck parameters were only investigated by two to three studies. However, these parameters seemed promising for the prediction of sac remodeling. For hostile neck anatomy, neck length, infrarenal neck angulation, and patency of the inferior mesenteric artery, no significant association with any category of AAA sac remodeling was found. The present review demonstrates neck thrombus, AAA thrombus, number of hostile neck parameters, total AAA volume, AAA flow-lumen volume, and aortic calcification as important anatomic features that are likely to play a role in AAA remodeling after endovascular repair and should be further explored using advanced imaging techniques. We also found that strong, consistent evidence regarding the anatomic predictors of AAA sac remodeling after EVAR is lacking. Therefore, further research with large patient groups for a broad range of predictors of AAA sac change after EVAR is needed to complement the current gap in the evidence.

Verified
Journal Article
Open access
PDF file
RRRianne Eva van Rijswijk
Rianne Eva van Rijswijk
EJErik Groot Jebbink
Erik Groot Jebbink
SHSuzanne Holewijn
Suzanne Holewijn
NSNicky Stoop
Nicky Stoop
SSSteven M. van Sterkenburg
Steven M. van Sterkenburg
MRMichel Reijnen
Michel Reijnen
Recent studies demonstrate that patients with a shrinking abdominal aortic aneurysm (AAA), one-year after endovascular repair (EVAR), have better long-term outcomes than patients with a stable AAA. It is not known what factors determine whether an AAA will shrink or not. In this study, a range of parameters was investigated to identify their use in differentiating patients that will develop a shrinking AAA from those with a stable AAA one-year after EVAR. Hundred-seventy-four patients (67 shrinking AAA, 107 stable AAA) who underwent elective, infrarenal EVAR were enrolled between 2011–2018. Long-term survival was significantly better in patients with a shrinking AAA, compared to those with a stable AAA (p = 0.038). Larger preoperative maximum AAA diameter was associated with an increased likelihood of developing AAA shrinkage one-year after EVAR—whereas older age and larger preoperative infrarenal β angle were associated with a reduced likelihood of AAA shrinkage. However, this multivariate logistic regression model was only able to correctly identify 66.7% of patients with AAA shrinkage from the total cohort. This is not sufficient for implementation in clinical care, and therefore future research is recommended to dive deeper into AAA anatomy, and explore potential predictors using artificial intelligence and radiomics.

30 January 2025 in Journal of Endovascular Therapy
Verified
Journal Article
Open access
RRRianne Eva van Rijswijk
Rianne Eva van Rijswijk
MBMarko Bogdanovic
Marko Bogdanovic
JRJoy Roy
Joy Roy
KYKak Khee Yeung
Kak Khee Yeung
CZClark Zeebregts
Clark Zeebregts
MRMichel M. P. J. Reijnen
Michel M. P. J. Reijnen
Purpose: The goal of the study described in this protocol is to build a multimodal artificial intelligence (AI) model to predict abdominal aortic aneurysm (AAA) shrinkage 1 year after endovascular aneurysm repair (EVAR). Methods: In this retrospective observational multicenter study, approximately 1000 patients will be enrolled from hospital records of 5 experienced vascular centers. Patients will be included if they underwent elective EVAR for infrarenal AAA with initial assisted technical success and had imaging available of the same modality preoperatively and at 1-year follow-up (CTA-CTA or US-US). Data collection will include baseline and vascular characteristics, medication use, procedural data, preoperative and postoperative imaging data, follow-up data, and complications. Proposed Analyses: The cohort will be stratified into 3 groups of AAA remodeling based on the maximum AAA diameter difference between the preoperative and 1-year postoperative moment. Patients with a diameter reduction of ≥5 mm will be assigned to the AAA shrinkage group, cases with an increase of ≥5 mm will be assigned to the AAA growth group, and patients with a diameter increase or reduction of <5 mm will be assigned to the stable AAA group. Furthermore, an additional fourth group will include all patients who underwent an AAA-related reintervention within the first year after EVAR, because both the complication and the reintervention might have influenced the state of AAA remodeling at 1 year. The preoperative and postoperative CTA scans will be used for anatomical AAA analysis and biomechanical assessment through semi-automatic segmentation and finite element analysis. All collected clinical, biomechanical, and imaging data will be used to create an AI prediction model for AAA shrinkage. Explainable AI techniques will be used to identify the most descriptive input features in the model. Predicting factors resulting from the AI model will be compared with conventional univariate and multivariate logistic regression analyses to find the best model for the prediction of AAA shrinkage. The study is registered at www.clinicaltrials.gov under the registration number NCT06250998. Clinical Impact: This study aims to develop a robust and high-performance AI model for predicting AAA shrinkage one-year after EVAR, with great potential for optimizing both EVAR treatment and follow-up. The model can identify cases with an initially lower chance of early AAA shrinkage, in whom EVAR-treatment could be tailored by including additional preoperative coil embolization, active sac management and/or postoperative tranexamic acid therapy, which have shown to promote AAA shrinkage rate but are too complex and costly to perform in all patients. The model could aid in stratification of post-EVAR surveillance based on the patient’s individual risk and possibly decrease follow-up for the 40-50% of patients who will experience AAA sac shrinkage. Overall, the AI prediction model is expected to improve patient survival and decrease the number of reinterventions after EVAR and associated healthcare costs.

19 July 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
SLSteven J.G. Leeuwerke
Steven J.G. Leeuwerke
RRRianne Eva van Rijswijk
Rianne Eva van Rijswijk
MHMarieke Haalboom
Marieke Haalboom
CZClark J. Zeebregts
Clark J. Zeebregts
RGRobert H. Geelkerken
Robert H. Geelkerken
MRMichel M.P.J. Reijnen
Michel M.P.J. Reijnen
Sac regression after endovascular aneurysm repair (EVAR) is associated with lower mortality and morbidity. Most endografts feature an expanded polytetrafluorethylene (ePTFE) or woven polyester body on a nitinol or stainless steel stent. Polyester endografts show less type II endoleaks, but more post-implantation inflammatory syndrome (PIS), which may influence abdominal aortic aneurysm (AAA) sac remodelling. This study evaluated whether endograft fabric influences sac remodelling after elective infrarenal EVAR. This was a retrospective, two centre cohort study including patients with AAA who were electively treated between January 2011 and November 2021 with infrarenal contemporary endografts. Data originated from medical files, duplex ultrasound, and or computed tomography. The primary endpoint was sac remodelling at one year follow up. Secondary endpoints included sac remodelling at latest follow up, incidence of PIS, AAA related complications, secondary interventions, endoleak, and death. Among 337 patients who met the inclusion criteria, 256 (76.0%) received a polyester endograft and 81 (24.0%) received an ePTFE endograft. Median follow up was 74.7 months (interquartile range 27.8, 107.1). The Endurant II (n = 153; 45.4%), Anaconda (n = 98; 29.1%), and Gore Excluder (n = 65; 19.3%) accounted for 93.8% of cases. Sac remodelling was similar between polyester and ePTFE endografts at one year (p= .17) and at latest follow up (p= .81), which was confirmed in multivariate analysis (p = .24 and p = .36, respectively). The Anaconda showed both a higher rate of sac shrinkage and expansion after one year follow up compared with the Endurant II (p= .004). The incidence of PIS was 12.5%, with a higher prevalence of polyester endografts (p= .049). Sac remodelling was similar between patients with and without PIS after one year and at latest follow up (both p = .10). Sac remodelling did not differ between polyester and ePTFE endografts after elective infrarenal EVAR with contemporary endografts, but there were intraclass differences within the polyester group. The higher incidence of PIS with polyester endografts had no significant effect on sac remodelling.

5 August 2025 in Journal of Vascular Surgery
Verified
Journal Article
Open access
RRRianne Eva van Rijswijk
Rianne Eva van Rijswijk
SLSteven J.G. Leeuwerke
Steven J.G. Leeuwerke
DADieuwertje Alblas
Dieuwertje Alblas
RGRobert H. Geelkerken
Robert H. Geelkerken
MRMichel Reijnen
Michel Reijnen
JWJelmer Wolterink
Jelmer Wolterink
Recent findings show that patients with abdominal aortic aneurysm (AAA) sac regression after endovascular repair (EVAR) have significantly better long-term outcomes than patients with a stable or expanding sac. Previous studies have not yet identified strong predictors of sac regression, but suggest that anatomical AAA parameters might play a role in the remodeling. This study aimed to conduct a comprehensive analysis of preoperative AAA anatomy to identify predictors of sac regression 1 year after EVAR. This retrospective two-center cohort study included patients with regressing or stable sacs one-year after elective infrarenal EVAR between January 2011 and December 2019. The lumen and intraluminal thrombus (ILT) of the AAA were automatically segmented. From this, the center lumen line and a range of anatomical characteristics were automatically derived, including volume, diameter and length measurements, (hostile) neck parameters, ILT distribution, radiodensities, calcification, and aortic curvature. Logistic regression was performed to identify the added predictive value of the anatomical characteristics. Enrolled were 289 patients (84% male, 72.0 ± 7.4 years old) of whom 46% experienced sac regression and 54% had a stable sac 1 year after EVAR. Significant differences between the regression and stable group were found for the relative neck ILT volume (1.2 ± 1.6 vs 1.7 ± 2.2; P = .029), location of maximum thrombus thickness (187° ± 109° vs 156° ± 105°; P = .018), variation in ILT circumference (25 ± 10% vs 23 ± 10%; P = .029), the roundness of the lumen (1.46 ± 0.24 vs 1.52 ± 0.25; P = .029), and variation in lumen radiodensity (77 ± 25 Hounsfield units vs 85 ± 24 Hounsfield units; P = .005). No significant differences were observed for the other volumes, lengths, and (hostile) neck parameters. Compared with a baseline model that included only clinical variables, the addition of the anatomical variables increased the model sensitivity from 42.1% to 58.3% and the overall accuracy from 59.9% to 66.3%. For the receiver operating characteristic curve, the area under the curve also significantly improved by 0.08 to 0.71 when the anatomical variables were added. Anatomical AAA characteristics relating to ILT play an important role in sac regression after EVAR. Furthermore, this study supports the existing evidence confirming that various mostly geometric neck parameters are not associated with sac regression, such as diameter, calcification, length, angulation, shape, and presence of a hostile neck. Although the anatomical analysis is of added value for predicting sac regression, further improvement is needed before clinical implementation.

3 August 2026 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
RRRianne Eva van Rijswijk
Rianne Eva van Rijswijk
SESuzan R.T. Everink
Suzan R.T. Everink
HNHeleen S. van Nie
Heleen S. van Nie
JWJelmer Wolterink
Jelmer Wolterink
MRMichel Reijnen
Michel Reijnen
EJErik Groot Jebbink
Erik Groot Jebbink
Objectives: Three‐dimensional ultrasound (3D US) is emerging as a novel imaging method for abdominal aortic aneurysms (AAAs) as it creates a low‐cost 3D AAA overview without harmful radiation and nephrotoxic contrast agents, as opposed to conventional imaging. 3D US can be used with a non‐nephrotoxic contrast agent (3D‐CEUS) for lumen delineation. This study aims to compare 3D US and 3D‐CEUS using a commercially available 3D US system against contrast‐enhanced computed tomography (CTA). Methods: For twenty AAA patients, the total AAA was segmented for all 3 modalities, and the lumen was segmented in the 3D‐CEUS and CTA scans. The CTA segmentations were registered onto each 3D (CE)US segmentation, and evaluation metrics were computed, including the volumes, average surface distance, sensitivity, precision, and Dice score. Results: 3D US and 3D‐CEUS scans were feasible in all patients. Lumen volumes were significantly larger on 3D‐CEUS compared to CTA (94 versus 70 mL, p < .001). The total AAA volumes were significantly smaller on 3D US compared to CTA (142 versus 165 mL, p = .002), and comparable on 3D‐CEUS (176 versus 165 mL, p = .433). The Dice scores were overall acceptable, ranging from 0.82 to 0.88, and the average surface distances were 2.5 mm. Conclusions: This study demonstrated the feasibility of 3D US and 3D‐CEUS for AAA imaging with good correspondence to CTA. Addition of the contrast agent increased agreement of volume measurements. 3D US facilitated retrospective offline AAA assessment, which is a major added value compared to 2D US. For now, 3D US already seems a promising imaging modality, which has to be proven in a large‐scale study.